These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 33463157)

  • 1. Macroscopic Silicone Microchannel Matrix for Tailored Drug Release and Localized Glioblastoma Therapy.
    Rasch F; Schmitt C; Saure LM; Meyer R; Adamski V; Dengiz D; Scherließ R; Lucius R; Synowitz M; Mishra YK; Hattermann K; Adelung R; Held-Feindt J; Schütt F
    ACS Biomater Sci Eng; 2020 Jun; 6(6):3388-3397. PubMed ID: 33463157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AT101-Loaded Cubosomes as an Alternative for Improved Glioblastoma Therapy.
    Flak DK; Adamski V; Nowaczyk G; Szutkowski K; Synowitz M; Jurga S; Held-Feindt J
    Int J Nanomedicine; 2020; 15():7415-7431. PubMed ID: 33116479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A biopolymeric mesh enriched with PLGA microparticles loaded with AT101 for localized glioblastoma treatment.
    Hellmold D; Arnaldi P; Synowitz M; Held-Feindt J; Akbari M
    Biomed Mater; 2023 Apr; 18(3):. PubMed ID: 37054732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined treatment of AT101 and demethoxycurcumin yields an enhanced anti-proliferative effect in human primary glioblastoma cells.
    Mehner M; Kubelt C; Adamski V; Schmitt C; Synowitz M; Held-Feindt J
    J Cancer Res Clin Oncol; 2020 Jan; 146(1):117-126. PubMed ID: 31844979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of sequentially applied single and combined temozolomide, hydroxychloroquine and AT101 treatment in a long-term stimulation glioblastoma in vitro model.
    Adamski V; Schmitt C; Ceynowa F; Adelung R; Lucius R; Synowitz M; Hattermann K; Held-Feindt J
    J Cancer Res Clin Oncol; 2018 Aug; 144(8):1475-1485. PubMed ID: 29858681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment of a glioblastoma in vitro (in)complete resection dual co-culture model suitable for drug testing.
    Schmitt C; Adamski V; Rasch F; Adelung R; Lucius R; Synowitz M; Hattermann K; Held-Feindt J
    Ann Anat; 2020 Mar; 228():151440. PubMed ID: 31726206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the Anti-Tumorigenic Agent AT101 on Human Glioblastoma Cells in the Microenvironmental Glioma Stem Cell Niche.
    Caylioglu D; Meyer RJ; Hellmold D; Kubelt C; Synowitz M; Held-Feindt J
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33808494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sustained Delivery of Doxorubicin via Acetalated Dextran Scaffold Prevents Glioblastoma Recurrence after Surgical Resection.
    Graham-Gurysh E; Moore KM; Satterlee AB; Sheets KT; Lin FC; Bachelder EM; Miller CR; Hingtgen SD; Ainslie KM
    Mol Pharm; 2018 Mar; 15(3):1309-1318. PubMed ID: 29342360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decitabine nanoconjugate sensitizes human glioblastoma cells to temozolomide.
    Cui Y; Naz A; Thompson DH; Irudayaraj J
    Mol Pharm; 2015 Apr; 12(4):1279-88. PubMed ID: 25751281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-resection treatment of glioblastoma with an injectable nanomedicine-loaded photopolymerizable hydrogel induces long-term survival.
    Zhao M; Danhier F; Bastiancich C; Joudiou N; Ganipineni LP; Tsakiris N; Gallez B; Rieux AD; Jankovski A; Bianco J; Préat V
    Int J Pharm; 2018 Sep; 548(1):522-529. PubMed ID: 30017818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration.
    Clark PA; Bhattacharya S; Elmayan A; Darjatmoko SR; Thuro BA; Yan MB; van Ginkel PR; Polans AS; Kuo JS
    J Neurosurg; 2017 May; 126(5):1448-1460. PubMed ID: 27419830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulation and in vitro evaluation of 17-allyamino-17-demethoxygeldanamycin (17-AAG) loaded polymeric mixed micelles for glioblastoma multiforme.
    Saxena V; Hussain MD
    Colloids Surf B Biointerfaces; 2013 Dec; 112():350-5. PubMed ID: 24012704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in drug delivery technology for the treatment of glioblastoma multiforme.
    Cha GD; Kang T; Baik S; Kim D; Choi SH; Hyeon T; Kim DH
    J Control Release; 2020 Dec; 328():350-367. PubMed ID: 32896613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CREKA peptide-conjugated dendrimer nanoparticles for glioblastoma multiforme delivery.
    Zhao J; Zhang B; Shen S; Chen J; Zhang Q; Jiang X; Pang Z
    J Colloid Interface Sci; 2015 Jul; 450():396-403. PubMed ID: 25863222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel RGD containing, temozolomide-loading nanostructured lipid carriers for glioblastoma multiforme chemotherapy.
    Song S; Mao G; Du J; Zhu X
    Drug Deliv; 2016 May; 23(4):1404-8. PubMed ID: 26203687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-layered core-sheath fiber membranes for controlled drug release in the local treatment of brain tumor.
    Han D; Serra R; Gorelick N; Fatima U; Eberhart CG; Brem H; Tyler B; Steckl AJ
    Sci Rep; 2019 Nov; 9(1):17936. PubMed ID: 31784666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted Vascular Drug Delivery in Cerebral Cancer.
    Humle N; Johnsen KB; Arendt GA; Nielsen RP; Moos T; Thomsen LB
    Curr Pharm Des; 2016; 22(35):5487-5504. PubMed ID: 27464719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanoparticles: Novel vehicles in treatment of Glioblastoma.
    Pourgholi F; Hajivalili M; Farhad JN; Kafil HS; Yousefi M
    Biomed Pharmacother; 2016 Feb; 77():98-107. PubMed ID: 26796272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aptamer-Based In Vivo Therapeutic Targeting of Glioblastoma.
    Cesarini V; Scopa C; Silvestris DA; Scafidi A; Petrera V; Del Baldo G; Gallo A
    Molecules; 2020 Sep; 25(18):. PubMed ID: 32957732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perivascular signals alter global gene expression profile of glioblastoma and response to temozolomide in a gelatin hydrogel.
    Ngo MT; Harley BAC
    Biomaterials; 2019 Apr; 198():122-134. PubMed ID: 29941152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.